Next Article in Journal
Systematic Analysis of Aberrant Biochemical Networks and Potential Drug Vulnerabilities Induced by Tumor Suppressor Loss in Malignant Pleural Mesothelioma
Next Article in Special Issue
Survival in Cytologically Proven Node-Positive Breast Cancer Patients with Nodal Pathological Complete Response after Neoadjuvant Chemotherapy
Previous Article in Journal
Evolution of the Experimental Models of Cholangiocarcinoma
Article

No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials

1
Department of Radiation Oncology, Heinrich Heine University, 40225 Duesseldorf, Germany
2
Department of Radiation Oncology, LMU University, 81377 Munich, Germany
3
Department of Radiation Oncology, University Hospital Schleswig-Holstein, 24105 Kiel, Germany
4
Division of Biostatistics and Bioinformatics, Department of Oncology, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(8), 2309; https://doi.org/10.3390/cancers12082309
Received: 1 July 2020 / Revised: 4 August 2020 / Accepted: 10 August 2020 / Published: 17 August 2020
(This article belongs to the Special Issue Neoadjuvant Systemic Therapy in Early Breast Cancer)
Purpose/objective: Adjuvant radiotherapy after breast conserving surgery is the standard approach in early stage breast cancer. However, the extent of breast tissue that has to be targeted with radiation has not been determined yet. Traditionally, the whole breast was covered by two opposing tangential beams. Several randomized trials have tested partial breast irradiation (PBI) compared to whole breast irradiation (WBI) using different radiation techniques. There is evidence from randomized trials that PBI might result in lower mortality rates compared to WBI. We aimed to reassess this question using current data from randomized trials. Material/methods: We performed a systematic literature review searching for randomized trials comparing WBI and PBI in early stage breast cancer with publication dates after 2009. The meta-analysis was performed using the published event rates and the effect sizes for overall survival (OS), breast cancer-specific survival (BCSS), and non-breast cancer death (NBCD) as investigated endpoints. Analysis of subgroups using different radiation techniques was intended. We used hazard ratios (HR) and risk differences (RD) to estimate pooled effect sizes. Statistical analysis was performed using the inverse variance heterogeneity model. Results: We identified eleven studies randomizing between PBI and WBI. We did not find significant differences in OS (n = 14,070; HR = 1.02; CI-95%: 0.89–1.16; p = 0.810, and n = 15,203; RD = −0.001; CI-95%: −0.008–0.006; p = 0.785) and BCSS (n = 15,203; RD = 0.001; CI-95%: −0.002–0.005; p = 0.463). PBI also did not result in a significant decrease of NBCD (n = 15,203; RD = −0.003; CI-95%: −0.010–0.003; p = 0.349). A subgroup analysis by radiation technique also did not point to any detectable differences. Conclusion: In contrast to a previous assessment of mortality, we could not find a detrimental effect of WBI on OS or NBCD. A longer follow-up might be necessary to fully assess the long-term mortality effects of PBI compared to WBI. View Full-Text
Keywords: cancer; investigation; study; radiation therapy; randomized cancer; investigation; study; radiation therapy; randomized
Show Figures

Figure 1

MDPI and ACS Style

Haussmann, J.; Budach, W.; Corradini, S.; Krug, D.; Tamaskovics, B.; Bölke, E.; Djiepmo-Njanang, F.-J.; Simiantonakis, I.; Kammers, K.; Matuschek, C. No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials. Cancers 2020, 12, 2309. https://doi.org/10.3390/cancers12082309

AMA Style

Haussmann J, Budach W, Corradini S, Krug D, Tamaskovics B, Bölke E, Djiepmo-Njanang F-J, Simiantonakis I, Kammers K, Matuschek C. No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials. Cancers. 2020; 12(8):2309. https://doi.org/10.3390/cancers12082309

Chicago/Turabian Style

Haussmann, Jan, Wilfried Budach, Stefanie Corradini, David Krug, Balint Tamaskovics, Edwin Bölke, Freddy-Joel Djiepmo-Njanang, Ioannis Simiantonakis, Kai Kammers, and Christiane Matuschek. 2020. "No Difference in Overall Survival and Non-Breast Cancer Deaths after Partial Breast Radiotherapy Compared to Whole Breast Radiotherapy—A Meta-Analysis of Randomized Trials" Cancers 12, no. 8: 2309. https://doi.org/10.3390/cancers12082309

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop